Top Markets
Coin of the day
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
株式のランク #31432
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
株価
$4.11
時価総額
$13.80M
変化(1日)
3.92%
変化(1年)
90.05%
US
取引 GridAI Technologies Corp. (GRDX)

カテゴリー

GridAI Technologies Corp.(GRDX)の配当利回りの履歴
GridAI Technologies Corp.(銘柄コード: GRDX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
GridAI Technologies Corp.(GRDX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)
企業 配当利回り
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE